top of page
Monoclonal Antibody Discovery & Antibody Development
We develop novel monoclonal antibodies for the pharmaceutical industry and academia as highly specialized therapeutics, diagnostics, or impactful research tools in biomedical research.
MABY is a spin-off company from the Biomedical Sciences Research Center (BSRC) “A. Fleming”
OUR PARTNERS & COLLABORATORS
bottom of page